Company

HERON THERAPEUTICS, INC. /DE/ (HRTX)

Standardized SEC financial data for HERON THERAPEUTICS, INC. /DE/ — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000818033 · NASDAQ · Pharmaceutical Preparations.

Gross margin

73.3%

Operating margin

-1.6%

Net margin

-13.0%

Revenue growth (YoY)

7.4%

Return on equity

-140.9%

Free cash flow

-$27.9M

Current ratio

2.48×

EPS (diluted)

$-0.12

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$88.6M	$86.3M	$107.7M	$127.0M	$144.3M	$154.9M
Cost of revenue	$36.2M	$46.0M	$54.9M	$65.1M	$38.6M	$41.3M
Gross profit	$52.4M	$40.3M	$52.8M	$61.9M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$208.5M	$157.6M	$84.9M	$80.4M	$59.3M	$46.6M
Inventory	$41.9M	$48.4M	$54.6M	$42.1M	$53.2M	$92.7M
Total current assets	$314.2M	$254.4M	$205.4M	$188.8M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$184.8M	-$203.4M	-$146.9M	-$58.8M	-$22.5M	-$27.6M
Capital expenditures	$6.8M	$3.0M	$1.8M	$1.5M	$1.7M	$317K
Free cash flow	-$191.6M	-$206.4M	-$148.7M	-$60.3M

Get HRTX data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/HRTX/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/HRTX/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View HRTX filings on SEC EDGAR →